Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Fireman

Showing results (171-180 of 209) with videos related to

Pageof 21
Sort By:
JAMA|September 3, 2021
Surveillance for Adverse Events After COVID-19 mRNA VaccinationNicola P Klein, Ned Lewis, Kristin Goddard, et al.
MMWR. Morbidity and Mortality Weekly Report|July 15, 2021
COVID-19 Vaccination Coverage Among Insured Persons Aged ≥16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021Cassandra Pingali, Mehreen Meghani, Hilda Razzaghi, et al.
Pharmacoepidemiology and Drug Safety|January 11, 2018
Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel SystemElizabeth A Chrischilles, Joshua J Gagne, Bruce Fireman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 16, 2023
Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season: VISION NetworkKatherine Adams, Zachary A Weber, Duck-Hye Yang, et al.
Pediatrics|May 18, 2022
Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 YearsAnne M Hause, David K Shay, Nicola P Klein, et al.
Vaccine|October 25, 2025
Near real-time surveillance and tree-based data mining to assess the safety of respiratory syncytial virus vaccines in older adults in the vaccine safety datalinkJames G Donahue, Noelle M Cocoros, Burney A Kieke, et al.
The Journal of Infectious Diseases|February 22, 2023
Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19-Associated Encounters in Adults During Delta and Omicron PredominanceCatherine H Bozio, Kristen A Butterfield, Melissa Briggs Hagen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2025
Patterns in prescribing and dispensing of influenza antivirals among adults with influenza presenting to urgent care and emergency department settings, VISION Network, 2023-2024Katherine Adams, Shikha Garg, Sara Y Tartof, et al.
Obstetrics and Gynecology|December 11, 2025
Effectiveness of 2023-2024 Coronavirus Disease 2019 (COVID-19) Vaccines in Pregnant WomenAllison Avrich Ciesla, Victoria Lazariu, Janet A Watts, et al.
The Journal of Infectious Diseases|July 25, 2024
Influenza Vaccine Effectiveness Against Influenza A-Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022-2023Mark W Tenforde, Zachary A Weber, Duck-Hye Yang, et al.
Pageof 21

Showing results (171-180 of 209) with videos related to

Sort By:
Pageof 21
JAMA|September 3, 2021
Surveillance for Adverse Events After COVID-19 mRNA VaccinationNicola P Klein, Ned Lewis, Kristin Goddard, et al.
MMWR. Morbidity and Mortality Weekly Report|July 15, 2021
COVID-19 Vaccination Coverage Among Insured Persons Aged ≥16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021Cassandra Pingali, Mehreen Meghani, Hilda Razzaghi, et al.
Pharmacoepidemiology and Drug Safety|January 11, 2018
Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel SystemElizabeth A Chrischilles, Joshua J Gagne, Bruce Fireman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 16, 2023
Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season: VISION NetworkKatherine Adams, Zachary A Weber, Duck-Hye Yang, et al.
Pediatrics|May 18, 2022
Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 YearsAnne M Hause, David K Shay, Nicola P Klein, et al.
Vaccine|October 25, 2025
Near real-time surveillance and tree-based data mining to assess the safety of respiratory syncytial virus vaccines in older adults in the vaccine safety datalinkJames G Donahue, Noelle M Cocoros, Burney A Kieke, et al.
The Journal of Infectious Diseases|February 22, 2023
Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19-Associated Encounters in Adults During Delta and Omicron PredominanceCatherine H Bozio, Kristen A Butterfield, Melissa Briggs Hagen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 4, 2025
Patterns in prescribing and dispensing of influenza antivirals among adults with influenza presenting to urgent care and emergency department settings, VISION Network, 2023-2024Katherine Adams, Shikha Garg, Sara Y Tartof, et al.
Obstetrics and Gynecology|December 11, 2025
Effectiveness of 2023-2024 Coronavirus Disease 2019 (COVID-19) Vaccines in Pregnant WomenAllison Avrich Ciesla, Victoria Lazariu, Janet A Watts, et al.
The Journal of Infectious Diseases|July 25, 2024
Influenza Vaccine Effectiveness Against Influenza A-Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022-2023Mark W Tenforde, Zachary A Weber, Duck-Hye Yang, et al.
Pageof 21